976.96
0.32%
+3.16
시간 외 거래:
976.96
왜 Regeneron Pharmaceuticals, Inc. (REGN) 주가가 하락하고 있습니까?
2023-06-27:
REGN's stock fell 8.71% following The Food and Drug Administration (FDA)'s rejection of an 8-milligram-dose version of Regeneron Pharmaceuticals' eye drug Eylea.
자본화:
|
볼륨(24시간):